
Erlotinib Tablet - Receptor Tyrosine Kinase Inhibitor, Advanced Cancer Treatment For Non-small Cell Lung And Pancreatic Cancer
Price:
Get Latest Price
In Stock
Product Specifications
Dosage | 100mg, 150mg |
Form | Tablet |
Packaging | Blister packs |
Ingredients | Erlotinib hydrochloride |
Storage | Room temperature |
Shelf life | 2 years |
Route | Oral |
Features | Cancer treatment, Targeted therapy, EGFR inhibitor, Effective dosage, Convenient packaging |
Payment Terms | Others, Cash Advance (CA) |
Main Export Market(s) | Eastern Europe, Western Europe, Middle East, Africa, South America, Asia, Central America, North America, Australia |
Main Domestic Market | All India |
Product Overview
Key Features
Erlotinib hydrochloride is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. It is a receptor tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR).
Company Details
Established in 1991 in Hyderabad, India, Vivimed Labs has metamorphosed from a domestic small, entrepreneurial family-operated business to a globally renowned supplier of niche molecules and formulations across Healthcare, Pharmaceuticals and Specialty Chemicals consumers in nearly 50 countries.
Business Type
Exporter, Manufacturer, Distributor, Supplier, Wholesaler, Retailer, Dealer
Employee Count
73422
Establishment
1956
Working Days
Monday To Sunday
GST NO
37AAACV6060A1ZO
Related Products
Explore Related Categories
More Product From This seller
Seller Details
GST - 37AAACV6060A1ZO
Hyderabad, Telangana
Mr Andrew G Hall
Address
Vivimed Labs Ltd. North End, Road No.2, Banjara Hills, Hyderabad, Telangana, 500034, India
erlotinib tablets in Hyderabad
Report incorrect details